Genetic and environmental factors in colorectal cancer Mutations in the adenomatous polyposis coli gene in patients and in animal models;Genetiske og miljømessige faktorer ved kolorektal kreft Mutasjoner i genet for familiasr adenomat0s polypose

Tidsskrift for den Norske Laegeforening

Volumn 117, Issue 14, 1997, Pages 2046-2051

  Steffensen, Inger Lise ^a   Paulsen, Jan Erik ^a   Alexander, Jan ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

MUTAGENIC AGENT;

ANIMAL; COLON POLYPOSIS; COLON TUMOR; ENVIRONMENTAL EXPOSURE; FEEDING BEHAVIOR; FEMALE; GENETICS; HUMAN; MALE; MOUSE; MUTATION; RAT; RECTUM TUMOR; REVIEW; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI; ANIMALS; COLONIC NEOPLASMS; ENVIRONMENTAL EXPOSURE; FEMALE; FOOD HABITS; GENES, APC; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICE; MUTAGENS; MUTATION; RATS; RECTAL NEOPLASMS;

EID: 0031591220     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kreft i Norge 1992. Oslo: Kreftregisteret, Institutt for epidemiologisk kreftforskning, 1995.
2. Allen JI. Molecular biology of colon polyps and colon cancer. Semin Surg Oncol 1995; 11: 399-405.
3. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
4. Miyaki M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Konishi M. Familial polyposis: recent advances. Crit Rev Oncol Hematol 1995; 19: 1-31.
5. Lang NP, Butler MA, Massengill J, Lawson M, Stotts RC, Hauer-Jensen M et al. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to foodborne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol Biomarkers Prev 1994; 3: 675-82.
6. Kinzler KW, Nilbert MC, Su L-K, Vogelstein B, Bryan TM, Levy DB et al. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253: 661-5.
7. Caspari R, Olschwang S, Friedl W, Mandl M, Boisson C, Böker T et al. Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 1995; 4: 337-40.
8. Su L-K, Johnson KA, Smith KJ, Hill DE, Vogelstein B, Kinzler KW. Association between wild type and mutant APC gene products. Cancer Res 1993; 53: 2728-31.
9. Munemitsu S, Souza B, Müller O, Albert I, Rubinfeld B, Polakis P. The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res 1994; 54:3676-81.
10. Su L-K, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993; 262: 1734-7.
11. Burchill SA. The tumour suppressor APC gene product is associated with cell adhesion. Bioessays 1994; 16: 225-7.
12. Baeg G-H, Matsumine A, Kuroda T, Bhattacharjee RN, Miyashiro I, Toyoshima K et al. The tumour suppressor gene product APC blocks cell cycle progression from Go/G, to S phase. EMBO J 1995; 14: 5618-25.
13. Wong MH, Hermiston ML, Syder AJ, Gordon JI. Forced expression of the tumor suppressor adenomatosis polyposis coli protein induces disordered cell migration in the intestinal epithelium. Proc Natl Acad Sci USA 1996; 93: 9588-93.
14. Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, Nakatsuru S et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1992; 1: 229-33.
15. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR. Thibodeau SN et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992; 359: 235-7.
16. Miyaki M, Konishi M, Kikuchi-Yanoshita R, Enomoto M, Igari T, Tanaka K et al. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res 1994; 54: 3011-20.
17. Kakiuchi H, Watanabe M, Ushijima T. Toyota M, Imai K, Weisburger JH et al. Specific 5'GGGA-3' -> 5'-GGA-3' mutation of the Ape gene in rat colon tumors induced by 2-amino1 -methy 1-6-pheny limidazo[4,5-b]pyridine. Proc Natl Acad Sci USA 1995; 92: 910-4.
18. Moser AR, Pilot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990; 247: 322-4.
19. Luongo C, Moser AR, Gledhill S, Dove WF. Loss of Ape1 in intestinal adenomas from Min mice. Cancer Res 1994; 54: 5947-52.
20. Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, Taketo M. Loss of Ape heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Ape gene. Proc Natl Acad Sci USA 1995; 92: 4482-6.
21. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E et al. Suppression of intestinal polyposis in ApcA7lfl knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87: 803-9.
22. Reitmair AH, Cai JC, Bjerknes M, Redston M, Cheng H, Pind MTL et al. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis. Cancer Res 1996; 56: 2922-6.
23. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 1987; 37: 147-51.
24. Paulsen JE, Namork E, Steffensen 1-L, Alexander J. Morphological discrepancy between spontaneous and azoxymethane-induced aberrant crypts in the colon of MIN mice. Proc Am Assoc Cancer Res 1996; 37: 110.
25. Steffensen 1-L, Paulsen JE, Eide TJ, Alexander J. 2-Amino-l-methyl-6-phenylimidazo[4,5bJ pyridine (PhIP) increases the numbers of tumors, cystic crypts and aberrant crypt foci in multiple intestinal neoplasia (Min) mice. Carcinogenesis 1997; akseptert for publisering. O